(Q36154721)

12 August 2017

A comparison of hepatopathologists' and community pathologists' review of liver biopsy specimens from patients with hepatitis C. (English)

1 reference

12 August 2017

5

Stephanie Bialek

1 reference

12 August 2017

Maire Robert

1

1 reference

12 August 2017

Andre N Sofair

2

1 reference

12 August 2017

Ann Thomas

3

1 reference

12 August 2017

Beth Bell

4

1 reference

12 August 2017

Christopher Corless

6

1 reference

12 August 2017

Grace Van Ness

7

1 reference

12 August 2017

Sharon Huie-White

8

1 reference

12 August 2017

Nicole Stabach

9

1 reference

12 August 2017

Atif Zaman

10

1 reference

12 August 2017

language of work or name

English

0 references

publication date

13 December 2008

1 reference

Clinical Gastroenterology and Hepatology

12 August 2017

1 reference

12 August 2017

7

1 reference

12 August 2017

3

1 reference

12 August 2017

335-338

1 reference

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603363

National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603363

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603363

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603363

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603363

The nomenclature of chronic active hepatitis: an obituary.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603363

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603363

Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603363

A comparison of the accuracy of peritoneoscopy and liver biopsy in the diagnosis of cirrhosis

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603363

Sampling Variability on Percutaneous Liver Biopsy

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603363

Sources of variability in histological scoring of chronic viral hepatitis

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603363

Interobserver variation in interpretation of serial liver biopsies from patients with chronic hepatitis C.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603363

Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603363

Reproducibility of liver biopsy diagnosis in relation to the size of the specimen

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603363

Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603363

Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19138761

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19138761

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19138761

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.CGH.2008.11.029

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

19138761

1 reference